A novel decentralized clinical trial found that Paxlovid was ineffective in alleviating long COVID symptoms but underscored ...

Researchers had known that there was something odd about the development of MS, and attributed it to the so-called hygiene ...

Hauser frets that amid federal cutbacks, young scientists may turn away from medical research, knee-capping health care ...

A researcher at the University of California, San Francisco was honored Saturday for transforming the understanding and treatment of multiple sclerosis, the university said. Dr.

Traws Pharma, Inc. ( NASDAQ: TRAW) Virtual Investor Event March 31, 2025 10:00 AM ET Werner Cautreels – Chief Executive Officer Robert Redfield – Chief Medical Officer David Pauza – Chief Science ...

Common cold symptoms tend to affect the upper airways, like the nose, head, and throat. Learn how symptoms progress with a ...

Narry, director of the Center for RNA Research at the Institute for Basic Science (IBS), has uncovered a key cellular mechanism that ... developed an oral antiviral drug candidate for COVID ...

Echinacea is a well-known immune booster often used to prevent and treat respiratory infections. Its ability to enhance the immune response can help the body fight off pathogens contributing to ...

I’m well aware that the antiviral group did ... to a world in which anti-obesity drugs actually work. I remind everyone that metabolic disease is the natural homeland of compounds whose effects are ...